Cited by 29Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatmentsNeurological Disease Mechanisms and Treatments

The involvement of microglia in Alzheimer's disease: a new dog in the fight

Open access
Moore, Zachery, Taylor, Juliet M, Crack, Peter J·2019·British Journal of Pharmacology

Abstract

First described clinically in 1906, Alzheimer's disease (AD) is the most common neurodegenerative disease and form of dementia worldwide. Despite its prevalence, only five therapies are currently approved for AD, all dealing with the symptoms rather than the underlying causes of the disease. A multitude of experimental evidence has suggested that the once thought inconsequential process of neuroinflammation does, in fact, contribute to the AD pathogenesis. One such CNS cell type critical to this process are microglia. Plastic in nature with varied roles, microglia are emerging as key contributors to AD pathology. This review will focus on the role of microglia in the neuroinflammatory response in AD, highlighting recent studies implicating aberrant changes in microglial function in disease progression. Of critical note is that with these advances, a reconceptualization of the framework in which we view microglia is required. LINKED ARTICLES: This article is part of a themed section on Therapeutics for Dementia and Alzheimer's Disease: New Directions for Precision Medicine. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.18/issuetoc.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bph.14546

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 17

  1. Alexander SPH, Fabbro D, Kelly E, Marrion NV, Peters JA, Faccenda E , et al. (2017). THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Catalytic receptors. British Journal of Pharmacology 174 : S225-S271.
  2. Bamberger ME, Harris ME, McDonald DR, Husemann J, & Landreth GE (2003). A Cell Surface Receptor Complex for Fibrillar β-Amyloid Mediates Microglial Activation. The Journal of Neuroscience 23 : 2665.
  3. Boche D, Perry VH, & Nicoll JA (2013). Review: activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol 39 : 3-18.
  4. Burstein A, Sabbagh M, Andrews R, Valcarce C, Dunn I, & Altstiel L (2018). Development of Azeliragon, an oral small molecule antagonist of the receptor for advanced glycation Endproducts, for the potential slowing of loss of cognition in mild Alzheimer's Disease. The journal of prevention of Alzheimer's disease 5 : 149-154.
  5. Conde JR, & Streit WJ (2006). Microglia in the Aging Brain. Journal of Neuropathology & Experimental Neurology 65 : 199-203.
  6. Corder E, Saunders A, Strittmatter W, Schmechel D, Gaskell P, Small G , et al. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 : 921-923.
  7. Crocker PR, McMillan SJ, & Richards HE (2012). CD33 -related siglecs as pot modulators of inflammatory responses. Annals of the New York Academy of Sciences 1253 : 102-111.
  8. Eikelenboom P, Veerhuis R, Scheper W, Rozemuller AJM, Van Gool WA, & Hoozemans JJM (2006). The significance of neuroinflammation in understanding Alzheimer's disease. Journal of neural transmission 113 : 1685-1695.
  9. Godbout J, Chen J, Abraham J, Richwine A, Berg B, Kelley K , et al. (2005). Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. The FASEB journal 19 : 1329-1331.
  10. Gomez-Nicola D, Fransen NL, Suzzi S, & Perry VH (2013). Regulation of Microglial Proliferation during Chronic Neurodegeneration. Journal of Neuroscience 33 : 2481-2493.
  11. Kim J, Kwon J, Kim M, Do J, Lee D, & Han H (2016). Low-dielectric-constant polyimide aerogel composite films with low water uptake. Polymer Journal 48 : 829-834.
  12. Liu S, Liu Y, Hao W, Wolf L, Kiliaan AJ, Penke B , et al. (2012). TLR2 Is a Primary Receptor for Alzheimer's Amyloid β Peptide To Trigger Neuroinflammatory Activation. The Journal of Immunology 188 : 1098-1107.
  13. Mandrekar S, Jiang Q, Lee CYD, Koenigsknecht-Talboo J, Holtzman DM, & Landreth GE (2009). Microglia Mediate the Clearance of Soluble Aβ through Fluid Phase Macropinocytosis. The Journal of Neuroscience 29 : 4252-4262.
  14. Norden DM, & Godbout JP (2013). Review: microglia of the aged brain: primed to be activated and resistant to regulation. Neuropathol Appl Neurobiol 39 : 19-34.
  15. Ohsawa K, Imai Y, Sasaki Y, & Kohsaka S (2004). Microglia/macrophage-specific protein Iba1 binds to fimbrin and enhances its actin-bundling activity. Journal of Neurochemistry 88 : 844-856.
  16. Pimplikar SW (2009). Reassessing the Amyloid Cascade Hypothesis of Alzheimer's Disease. The international journal of biochemistry & cell biology 41 : 1261-1268.
  17. Walker FR, Beynon SB, Jones KA, Zhao Z, Kongsui R, Cairns M , et al. (2014). Dynamic structural remodelling of microglia in health and disease: A review of the models, the signals and the mechanisms. Brain, Behavior, and Immunity 37 : 1-14.

Cited by

Sorted by citations

Authors
Moore, Z., Taylor, J. M., & Crack, P. J.
Affiliations
The University of Melbourne (AU)
Corresponding author
  • Taylor, Juliet M
  • Crack, Peter J
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2018-12-18
Volume
176
Issue
18
Pages
3533-3543
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2901487590
Cited by
29
References
37
Citations by year
2026: 1 · 2025: 3 · 2024: 3 · 2023: 5 · 2022: 6 · 2021: 2 · 2020: 6 · 2019: 2 · 2018: 1
FWCI
0.26
Type
journal article
Language
en
Open access
Locations
  • British Journal of Pharmacology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion)
Funders
National Health and Medical Research Council (APP114989)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
Alzheimer's disease, microglia, neuroinflammation, microglial dysfunction, neurodegeneration, dementia, pathogenesis, precision medicine
MeSH terms
Alzheimer Disease, Animals, Humans, Microglia, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review